Viral Vector Manufacturing Market Size, Share and Forecast 2026
The Viral Vector Manufacturing Market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 20, 2019 ) Market Overview:
Gene therapy is used as a treatment option for most of the chronic diseases like cancers, genetic disorders, cardiovascular diseases, and infectious pathogen neurological disorders. It involves the insertion of a functional copy of a gene into a defective cell. Viral vectors are tools used by molecular biologists in the efficient transfer of therapeutic gene into the target cells.
Market Dynamics:
The major factors driving the market are an increase in funding, pipeline researches in various phases of clinical progression, the ability of vectors to express therapeutic genes efficiently, and nonpathogenic nature of vectors. The high price of gene therapies, short shelf-life of viral vectors, and possible risk of mutagenesis are going to restrain the market over the period of forecast.
Market Segmentation:
By Type
• Retroviral Vectors
• Adenoviral Vectors. Adeno-Associated Viral Vectors
• Other Viral Vectors
By Disease
• Cancer
• Genetic Disorders
• Infectious Diseases
• Other Diseases
By Application
• Gene Therapy
• Vaccinology
By End User
• Pharmaceutical and Biopharmaceutical Companies
• Research Institutes
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Lonza *
• Merck
• Oxford BioMedica
• CGT Catapult
• Cobra Biologics
• UniQure
• Others
View full report: https://www.datamintelligence.com/research-report/viral-vector-manufacturing-market
Download free sample: https://www.datamintelligence.com/download-sample/viral-vector-manufacturing-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Gene therapy is used as a treatment option for most of the chronic diseases like cancers, genetic disorders, cardiovascular diseases, and infectious pathogen neurological disorders. It involves the insertion of a functional copy of a gene into a defective cell. Viral vectors are tools used by molecular biologists in the efficient transfer of therapeutic gene into the target cells.
Market Dynamics:
The major factors driving the market are an increase in funding, pipeline researches in various phases of clinical progression, the ability of vectors to express therapeutic genes efficiently, and nonpathogenic nature of vectors. The high price of gene therapies, short shelf-life of viral vectors, and possible risk of mutagenesis are going to restrain the market over the period of forecast.
Market Segmentation:
By Type
• Retroviral Vectors
• Adenoviral Vectors. Adeno-Associated Viral Vectors
• Other Viral Vectors
By Disease
• Cancer
• Genetic Disorders
• Infectious Diseases
• Other Diseases
By Application
• Gene Therapy
• Vaccinology
By End User
• Pharmaceutical and Biopharmaceutical Companies
• Research Institutes
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Lonza *
• Merck
• Oxford BioMedica
• CGT Catapult
• Cobra Biologics
• UniQure
• Others
View full report: https://www.datamintelligence.com/research-report/viral-vector-manufacturing-market
Download free sample: https://www.datamintelligence.com/download-sample/viral-vector-manufacturing-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results